CME Group Inc. $CME Shares Sold by Keybank National Association OH

Keybank National Association OH lowered its stake in shares of CME Group Inc. (NASDAQ:CME) by 5.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 133,820 shares of the financial services provider’s stock after selling 7,508 shares during the quarter. Keybank National Association OH’s holdings in CME Group were worth $35,058,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of CME. BlackRock Inc. bought a new stake in CME Group in the 2nd quarter valued at $6,749,965,000. Bank of America Corp DE grew its position in CME Group by 39.1% in the 1st quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider’s stock worth $1,187,290,000 after purchasing an additional 1,130,587 shares during the last quarter. Bank of New York Mellon Corp bought a new position in shares of CME Group during the 2nd quarter worth about $867,313,000. Alphabet Inc. bought a new position in shares of CME Group during the 2nd quarter worth about $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of CME Group during the 2nd quarter worth about $629,771,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on CME shares. Wall Street Zen raised shares of CME Group from a “sell” rating to a “hold” rating in a research report on Saturday, October 31st. Barclays lifted their target price on CME Group from $281.00 to $321.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 22nd. Piper Sandler reissued an “overweight” rating and set a $330.00 target price (up from $295.00) on shares of CME Group in a research report on Thursday, October 22nd. CLSA set a $367.00 price target on CME Group in a research note on Thursday, October 22nd. Finally, TD Cowen upped their price target on CME Group from $292.00 to $300.00 and gave the company a “buy” rating in a report on Monday, October 5th. Ten research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $314.44.

CME Group Stock Up 2.2%

Shares of CME stock opened at $315.86 on Thursday. The stock has a market cap of $113.06 billion, a P/E ratio of 25.46, a price-to-earnings-growth ratio of 3.77 and a beta of 0.15. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The stock has a fifty day moving average price of $284.54 and a 200 day moving average price of $281.22. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.71 billion. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The business’s revenue was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.68 earnings per share. Analysts predict that CME Group Inc. will post 12.35 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, December 11th. CME Group’s dividend payout ratio (DPR) is presently 42.66%.

Insider Activity at CME Group

In related news, CEO Terrence A. Duffy sold 15,000 shares of the company’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $274.44, for a total value of $4,116,600.00. Following the sale, the chief executive officer owned 40,630 shares of the company’s stock, valued at $11,150,497.20. The trade was a 26.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Sunil Cutinho sold 5,000 shares of the company’s stock in a transaction dated Tuesday, October 27th. The shares were sold at an average price of $298.70, for a total transaction of $1,493,500.00. Following the completion of the sale, the insider directly owned 20,037 shares in the company, valued at approximately $5,985,051.90. The trade was a 19.97% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 33,511 shares of company stock worth $9,714,580 in the last ninety days. Company insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.